Dr. Gunter is Reader in Cancer Epidemiology and Prevention in the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College. He is a molecular epidemiologist and his main research focus is the role of metabolic and endocrine pathways in cancer development and prognosis.
Examples of current research projects include:
- Metabolomic Profiling and Colorectal Cancer Development
- Steroid hormones, insulin and insulin-like growth factors in endometrial cancer prognosis
- Diabetes and Cancer Initiative
- Improving clinical endpoint definitions for epidemiologic studies in the BBMRI-LPC partnership
Dr Gunter is a co-investigator of the European Prospective Investigation into Cancer (EPIC)
Dr Gunter is co-director of the MSc in Epidemiology and leads modules on Principles and Methods of Epidemiology and Molecular Epidemiology. Dr Gunter is also an executive board member of the MRC Centre for Environment & Health and oversees the centre training programme
Dr Gunter is an editor for Cancer Research and a peer reviewer for numerous other scientific and medical journals
Education and Professional Employment
Oct 1994-July 1998 University of Oxford, B.A. Hons. Biochemistry
Oct 1998-May 2003 University of Cambridge, Ph.D. Molecular Epidemiology
Dec 2003-Dec 2005 National Cancer Institute, NIH, DHHS, USA; Post-doctoral fellow, Division of Cancer Epidemiology and Genetics
Dec 2005-Aug 2011 Albert Einstein College of Medicine, New York, USA; Department of Epidemiology and Population Health; 2005-2007, Instructor; 2007-2011, Assistant Professor
Sep 2011- Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health; Reader in Cancer Epidemiology.